Nguyen, P.V.; Aubry, C.; Boudaoud, N.; Gaubert, A.; Langlois, M.-H.; Marchivie, M.; Gaudin, K.; Arpin, C.; Barthélémy, P.; Kauss, T.
Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299. Pharmaceutics 2022, 14, 2317.
https://doi.org/10.3390/pharmaceutics14112317
AMA Style
Nguyen PV, Aubry C, Boudaoud N, Gaubert A, Langlois M-H, Marchivie M, Gaudin K, Arpin C, Barthélémy P, Kauss T.
Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299. Pharmaceutics. 2022; 14(11):2317.
https://doi.org/10.3390/pharmaceutics14112317
Chicago/Turabian Style
Nguyen, Phuoc Vinh, Clémentine Aubry, Narimane Boudaoud, Alexandra Gaubert, Marie-Hélène Langlois, Mathieu Marchivie, Karen Gaudin, Corinne Arpin, Philippe Barthélémy, and Tina Kauss.
2022. "Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299" Pharmaceutics 14, no. 11: 2317.
https://doi.org/10.3390/pharmaceutics14112317
APA Style
Nguyen, P. V., Aubry, C., Boudaoud, N., Gaubert, A., Langlois, M. -H., Marchivie, M., Gaudin, K., Arpin, C., Barthélémy, P., & Kauss, T.
(2022). Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299. Pharmaceutics, 14(11), 2317.
https://doi.org/10.3390/pharmaceutics14112317
